Knoop, Ann
Copenhagen University Hospital
2 papers on CoChatORCID 0000-0003-2898-1093
Most cited papers
- Verified
Preference for subcutaneous or intravenous administration of trastuzumab in patients with HER2-positive early breast cancer (PrefHer): an open-label randomised study
Pivot, X., Gligorov, J., Müller, V., Barrett-Lee, P., Verma, S., Knoop, A., Curigliano, G., Semiglazov, V., López-Vivanco, G., Jenkins, V., et al. (2013) · The Lancet Oncology
HER2/EGFR in Cancer ResearchGastric Cancer Management and Outcomes
Cited by 230
- Verified
A time and motion study of subcutaneous versus intravenous trastuzumab in patients with HER 2‐positive early breast cancer
De Cock, E., Pivot, X., Hauser, N., Verma, S., Kritikou, P., Millar, D., & Knoop, A. (2016) · Cancer Medicine
HER2/EGFR in Cancer ResearchHealth Systems, Economic Evaluations, Quality of Life
Cited by 112
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free